Current Opinion in Biomedical Engineering

Papers
(The H4-Index of Current Opinion in Biomedical Engineering is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Toward the use of muscle reinnveration for chronic bidirectional control of prostheses to improve functional outcomes of end users63
Using biophysical cues and biomaterials to improve genetic models56
From “high” to “how many”: How quantifying receptor abundance links genotype, environment, and therapeutic response53
Brainy biomaterials: Latest advances in smart biomaterials to develop the next generation of neural interfaces53
Smart orthopedic biomaterials and implants41
Porous microneedles: Transdermal salt bridge for biomedical device engineering39
AAV-based CRISPR-Cas9 genome editing: Challenges and engineering opportunities39
Bioresorbable vascular metallic scaffolds: Current status and research trends37
Outlook in tissue-engineered magnetic systems and biomagnetic control36
Mining microbial organisms to discover and characterize novel CRISPR-Cas systems33
Contents33
Design of biocompatible and self-antibacterial titanium surfaces for biomedical applications32
Emerging trends of discrete Poly(ethylene glycol) in biomedical applications31
Contents30
The prospect of electroceutical intervention and its implementation toward intractable neuromuscular diseases25
Defining omics-based biomarker signatures of metabolic dysfunction-associated steatotic liver disease (MASLD): In vitro studies25
Artificial intelligence-powered biomedical imaging: Recent achievements and challenges24
Beyond the nucleus: Translating engineered protein localization to chromatin modifying enzymes23
AI models for protein design are driving antibody engineering23
Biophysical determinants of nuclear shape and mechanics and their implications for genome integrity22
Aging and the extracellular matrix: A tumor-permissive microenvironment driving cancer progression21
0.15667295455933